IndiaOne Finance - Company Dashboard

Governance Classic Home

Lincoln Pharmaceuticals LtdPharmaceuticalsINE405C01035Consolidated₹605.75-0.65 (-0.11%)Jun-26

Valuation

Market Cap₹1.20K Cr

TTM PE12.49x

Forward PE11.82x

PEG1.28

Book Value₹378.25

P/B1.59x

TTM EPS₹48.16

Fwd EPS₹50.91

TTM Revenue₹694.24 Cr

TTM PAT₹96.44 Cr

TTM EBITDA₹101.29 Cr

TTM EBIT₹86.39 Cr

Last Qtr PAT₹36.23 Cr

Last Qtr EBITDA₹27.43 Cr

Last Qtr EBIT₹23.55 Cr

Profitability

ROE12.73%

ROCE16.91%

TTM NPM13.89%

TTM EBITDA %14.59%

Curr OPM17.98%

Last OPM6.35%

Curr NPM—

Last NPM—

Curr EPS₹18.09

Last EPS₹5.81

Balance sheet

Equity₹20.03 Cr

Reserve₹737.60 Cr

Total Debt₹4.42 Cr

D/E0.01x

Interest %0.72%

Curr Interest₹0.26 Cr

Price / range

Close₹601.55

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.55%

1W-3.09%

1M-1.87%

3M-1.17%

6M+0.74%

1Y+8.63%

2Y-17.51%

3Y+19.83%

5Y+54.22%

Diwali+25.44%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1868.90	₹4.48L Cr	37.08	14.50%
DIVISLAB	9410.50	₹2.50L Cr	85.39	17.45%
TORNTPHARM	4970.00	₹1.89L Cr	79.39	25.70%
ZYDUSLIFE	1161.00	₹1.16L Cr	25.87	16.94%
CIPLA	1386.10	₹1.12L Cr	33.21	9.75%
LAURUSLABS	2017.50	₹1.09L Cr	99.58	20.58%
MANKIND	2437.80	₹1.01L Cr	49.26	12.68%
DRREDDY	1198.30	₹1.00L Cr	30.97	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	177.28+15.1%	187.28	166.32	163.36	154.07	671.03
Other Income	24.26	-4.20	15.15	7.23	15.27	33.45
Total Income	201.55+19.0%	183.08	181.47	170.60	169.34	704.48
Interest	0.26	0.27	0.30	0.23	0.21	1.01
Expenditure	-153.99-15.0%	-166.38	-146.75	-141.79	-133.95	-588.86
PBDT	0	0	0	0	0	0
EBITDA	27.43+15.2%	24.85	23.59	25.42	23.81	97.68
Depreciation	-3.88	-3.68	-3.72	-3.62	-3.48	-14.50
EBIT	23.55+15.8%	21.17	19.87	21.80	20.33	83.18
PBT	47.55+34.4%	16.70	34.72	28.81	35.39	115.63
Tax	-11.32	-5.07	-6.12	-8.83	-7.71	-27.73
Equity	20.03	20.03	0	0	20.03	20.03
OPM	23.59	9.12	20.88	17.64	20.90	16.41
Net Profit	36.23+30.9%	11.63	28.60	19.98	27.68	87.89
NPM	17.98	6.35	17.20	12.23	16.35	12.48
EPS	18.09+30.9%	5.81	14.28	9.98	13.82	43.88

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	671.03+7.7%	623.23+7.4%	580.55+13.8%	510.31+8.1%	472.08+14.3%	413.06
Other Income	33.45	22.48	34.42	22.48	10	6.77
Total Income	704.48+9.1%	645.71+5.0%	614.97+15.4%	532.79+10.5%	482.08+14.8%	419.82
Expenditure	-588.86-9.8%	-536.52-8.9%	-492.73-14.0%	-432.34-12.0%	-386.15-14.0%	-338.81
Interest	-1.01	-1.88	-1.46	-2.03	-1.45	-1.44
PBDT	0	0	0	0	0	0
EBITDA	97.68-3.8%	101.49+1.6%	99.91+12.0%	89.17-6.6%	95.47+17.3%	81.36
Depreciation	-14.50	-12.90	-10.63	-9.17	-8.09	-5.67
EBIT	83.18-6.1%	88.59-0.8%	89.28+11.6%	80-8.4%	87.38+15.4%	75.69
PBT	115.63+5.9%	109.19-10.7%	122.24+21.7%	100.46+4.7%	95.93+18.4%	81.01
Tax	-27.73	-26.84	-28.94	-27.56	-26.57	-20.61
Equity	20.03	20.03	0	0	0	0
OPM (%)	16.41	16.91	20.00	19.00	20.00	19.00
Net Profit	87.89+6.7%	82.35-11.7%	93.31+28.0%	72.90+5.1%	69.36+14.8%	60.41
NPM (%)	12.48	12.75	15.00	14.00	14.00	14.00
EPS (Rs)	43.88+6.7%	41.11-11.7%	46.58+28.0%	36.40+5.1%	34.63+14.7%	30.20
CEPS	43.88	41.11	46.58	36.40	34.63	30.20

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	177.28+15.1%	187.28	166.32	163.36	154.07	671.03
Other Income	24.26	-4.20	15.15	7.23	15.27	33.45
Total Income	201.55+19.0%	183.08	181.47	170.60	169.34	704.48
Interest	0.26	0.27	0.30	0.23	0.21	1.01
Expenditure	-153.99-15.0%	-166.38	-146.75	-141.79	-133.95	-588.86
PBDT	0	0	0	0	0	0
EBITDA	27.43+15.2%	24.85	23.59	25.42	23.81	97.68
Depreciation	-3.88	-3.68	-3.72	-3.62	-3.48	-14.50
EBIT	23.55+15.8%	21.17	19.87	21.80	20.33	83.18
PBT	47.55+34.4%	16.70	34.72	28.81	35.39	115.63
Tax	-11.32	-5.07	-6.12	-8.83	-7.71	-27.73
Equity	20.03	20.03	0	0	20.03	20.03
OPM	23.59	9.12	19.13	16.89	20.90	16.41
Net Profit	36.23+30.9%	11.63	28.60	19.98	27.68	87.89
NPM	17.98	6.35	15.76	11.71	16.35	12.48
EPS	18.09+30.9%	5.81	14.28	9.98	13.82	43.88

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	671.03+7.7%	623.23+7.4%	580.55+13.8%	510.31+8.1%	472.12+11.3%	424.19
Other Income	33.45	22.48	34.42	22.47	10	5.66
Total Income	704.48+9.1%	645.71+5.0%	614.97+15.4%	532.78+10.5%	482.12+12.2%	429.85
Expenditure	-588.86-9.8%	-536.52-8.9%	-492.73-14.0%	-432.30-11.9%	-386.18-11.6%	-346.13
Interest	-1.01	-1.88	-1.47	-2.03	-1.45	-1.56
PBDT	0	0	0	0	0	0
EBITDA	97.68-3.8%	101.49+1.6%	99.92+12.0%	89.21-6.6%	95.48+9.5%	87.18
Depreciation	-14.50	-12.90	-10.63	-9.17	-8.09	-7.56
EBIT	83.18-6.1%	88.59-0.8%	89.29+11.6%	80.04-8.4%	87.39+9.8%	79.62
PBT	115.63+5.9%	109.19-10.7%	122.24+21.7%	100.48+4.7%	95.94+14.6%	83.72
Tax	-27.73	-26.84	-28.94	-27.58	-26.58	-21.47
Equity	20.03	20.03	0	0	0	0
OPM (%)	16.41	16.91	19.88	18.86	19.90	19.48
Net Profit	87.89+6.7%	82.35-11.7%	93.31+28.0%	72.90+5.1%	69.36+11.4%	62.25
NPM (%)	12.48	12.75	15.17	13.68	14.39	14.48
EPS (Rs)	43.88+6.7%	41.11-11.7%	46.58+28.0%	36.40+5.1%	34.63+11.3%	31.11
CEPS	43.88	41.11	46.58	36.40	34.63	31.11

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	1.8	12 Sep 2025
2024	Final Dividend	1.8	13 Sep 2024
2023	Final Dividend	1.5	15 Sep 2023
2022	Final Dividend	1.5	15 Sep 2022
2021	Final Dividend	1.5	16 Sep 2021
2020	Interim Dividend	1.5	05 Mar 2020
2019	Final Dividend	1.5	19 Sep 2019
2018	Final Dividend	1.5	19 Sep 2018
2017	Final Dividend	1.2	21 Sep 2017
2016	Final Dividend	1	23 Sep 2016
2015	Final Dividend	1	23 Sep 2015
2014	Final Dividend	0.6	25 Sep 2014
2013	Final Dividend	0.6	19 Sep 2013
2012	Final Dividend	0.6	20 Sep 2012
2011	Final Dividend	0.6	22 Sep 2011
2010	Final Dividend	1.2	23 Sep 2010
2009	Final Dividend	1.2	17 Sep 2009
2008	Final Dividend	0.24	18 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split